About
James Murdoch quits GlaxoSmithKline board role
… empire quit the board of GlaxoSmithKline. The son of the billionaire … knowledge of the crisis. But Glaxo (down 20.5p to 1 … to 677p). His departure from Glaxo is likely to prompt renewed …
GlaxoSmithKline Daily Live Feed
Latest GlaxoSmithKline News from GlaxoSmithKline Daily Report
-
27 Jan 23:41 GMT
-
27 Jan 22:14 GMT
US FDA approves Amylin's diabetes drug
… two delays, the Food and Drug Administration approved once-weekly injectable Bydureon … in the United States, the medicine faces a daunting competitive landscape … time for potential rivals from GlaxoSmithKline Plc and Sanofi to catch … -
27 Jan 21:37 GMT
New drugs laboratory for the Olympics
It has been announced by the London Organising Committee of the Olympic and Paralympic Games (LOCOG) that GlaxoSmithKline and King's College London, will operate the drugs laboratory for the 2012 London Olympics. The anti-doping laboratory will be... -
27 Jan 20:31 GMT
James Murdoch to exit drug giant board
… resigned from the board of GlaxoSmithKline (GSK), the pharmaceuticals giant says. Mr … as a non-executive director, GSK said. GSK said Mr Murdoch wished to … . Mr Murdoch will leave the GSK board following the annual general … -
27 Jan 19:55 GMT
James Murdoch resigns from British drug giant board
… resigned from the board of GlaxoSmithKline (GSK), the pharmaceuticals giant said on … re-election as a non-executive director. GSK stated there had been no … 's British newspaper division. GSK chairman Christopher Gent said: … - 27 Jan 19:51 GMT
-
27 Jan 19:14 GMT
James Murdoch quits Glaxo board
… remained supportive. Sir Christopher Gent, Glaxo chairman, said: "James has … part of a shake-up of Glaxo's non-executives that will … Robert as senior independent non-executive. Glaxo shares fell 20.5p to … -
27 Jan 17:31 GMT
James Murdoch to resign from board of drug firm GSK
… resigned from the board of GlaxoSmithKline, the pharmaceuticals giant said on … re-election as a non-executive director. GSK stated there had been no … 's British newspaper division. GSK chairman Christopher Gent said: … -
27 Jan 17:27 GMT
James Murdoch exiting GlaxoSmithKline board
GlaxoSmithKline GSK-N says that James Murdoch … re-election to the drug company's board. GSK said Mr. Murdoch … Mr. Murdoch will leave the GSK board following the annual general … -
27 Jan 17:08 GMT
James Murdoch to leave GlaxoSmithKline board
LONDON — GlaxoSmithKline says that James Murdoch has … re-election to the drug company's board. GSK said Murdoch wished … colleagues. Murdoch will leave the GSK board following the annual general … -
27 Jan 17:07 GMT
GlaxoSmithKline Crosses Below its 10-
Today, shares of GlaxoSmithKline (NYSE:GSK) have fallen below their 10-day … markets vaccines, prescription and over-the-counter medicines, as well as health-related consumer … system, gastro-intestinal and genetic disorders GlaxoSmithKline (NYSE:GSK) has potential upside of … -
27 Jan 16:55 GMT
James Murdoch to Quit Board of Drug Giant GlaxoSmithKline to ...
… seat on the board of drug giant GlaxoSmithKline to focus on his … board at Glaxo's annual shareholder meeting this year, Glaxo said … ; explained Glaxo chairman Sir Christopher Gent. A spokesman for the drug company … 't changed," with Glaxo believing that "the full … -
27 Jan 16:41 GMT
UPDATE 3-James Murdoch to quit GSK board
… to quit the board of drug maker GlaxoSmithKline as he spends more … 's British newspaper arm. GSK said board members were expected … ; Editing by David Cowell) Keywords: GLAXOSMITHKLINE/ (adveith.nair@thomsonreuters.com)(+44 … -
27 Jan 16:23 GMT
Research and Markets: Nanotechnology in Drug Delivery 2011-...
… patent extensions on existing drugs which nanotech drug delivery (NDD) will make … breaks down the current nanotechnology drug delivery market into geographic markets … : Accelrys AlphaRx Inc. Cephalon, Inc. GlaxoSmithKline IOTA NanoSolutions Ltd. Izon Science … -
27 Jan 16:22 GMT
Research and Markets: Nanotechnology in Drug Delivery 2011-...
… patent extensions on existing drugs which nanotech drug delivery (NDD) will make … breaks down the current nanotechnology drug delivery market into geographic markets … : Accelrys AlphaRx Inc. Cephalon, Inc. GlaxoSmithKline IOTA NanoSolutions Ltd. Izon Science … -
27 Jan 15:04 GMT
James Murdoch steps down from Glaxo board
… the board of pharmaceutical giant GlaxoSmithKline, the company announced today. Murdoch … Rupert Murdoch. According to a Glaxo spokesman speaking to the Wall … ," said Glaxo Chairman Sir Christopher Gent. Meanwhile, the drugs company also … -
27 Jan 15:00 GMT
Has GlaxoSmithKline Become the Perfect Stock?
… perfect stock, then decide if GlaxoSmithKline (NYS: GSK) fits the bill. The … ' (NAS: HGSI) Benlysta lupus drug, which has no competition, the … already reflect some uncertainty, but Glaxo needs to move forward successfully … -
27 Jan 14:40 GMT
BioMarin aims to scoop up rare disease drugs as orphan field ...
… Shire, Pfizer ($PFE), Sanofi ($SNY), GlaxoSmithKline ($GSK) and others showing a willingness … on the drugmakers' big appetites for rare disease drugs. For example … popular rare disease drug model BioMarin snares orphan drug upstart in $115M … -
27 Jan 14:40 GMT
James Murdoch quits GlaxoSmithKline board
… the corporate responsibility committee at Glaxo. Photograph: Murdo Macleod James Murdoch … the board of GlaxoSmithKline, the UK's largest drug company. The … the corporate responsibility committee at Glaxo in 2009 but has decided … -
27 Jan 14:37 GMT
James Murdoch leaving GlaxoSmithKline board
LONDON — GlaxoSmithKline says that James Murdoch has … re-election to the drug company's board. GSK said Murdoch wished … colleagues. Murdoch will leave the GSK board following the annual general … -
27 Jan 13:29 GMT
Murdoch quits Glaxo board
… remained supportive. Sir Christopher Gent, GSK chairman, said: “James has taken … contribution he has made” to GSK. Mr Murdoch is leaving as part of a shake-up of GSK’s non-executives that will see …
Tools
